Table 4 Worst nonhaematologic CTC toxicity grade per patienta

From: A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours

 

80 mg m−2 (No. of patients)

120 mg m−2 (No. of patients)

Bilirubin

  

 1

1

0

 2

0

0

ASAT

  

 1

0

0

 2

0

1

ALAT

  

 1

0

0

 2

0

0

 3/4

0

1

Creatinine

  

 1

3

1

 2

0

0

Mucositis

  

 1

3

0

 2

0

0

Nausea

  

 1

3

3

 2

1

0

Vomiting

  

 1

0

0

 2

1

0

Diarrhoea

  

 1

0

1

 2

0

0

Fever

  

 1

0

0

 2

1

0

Infections

  

 1

0

0

 2

1

0

Skin reactions

  

 1

1

0

 2

0

0

Anorexia

  

 1

2

0

 2

0

0

Fatigue

  

 1

1

0

 2

2

1

  1. aExcept bladder toxicity.
Back to article page